Cancer Research

NON-INVASIVE CANCER SOLUTIONS
Safe | Accurate | Easy on the Patient

WORLDWIDE

Accurate, affordable and NON-INVASIVE Cancer screening;
Clinically relevant, NON-INVASIVE test for complete diagnosis of cancer to substitute invasive tissue extraction;
NON-INVASIVE biopsy for diagnosis of brain lesions as per WHO classification of brain tumors;
Identification of viable treatment options against drug resistant cancers;
Risk-free, radiation-free monitoring of treatment response / recurrence;
Ultra Personalised Immunotherapy with Autologous Immune Cells.

CLINICAL TRIALS

Sr. No.	Name of Trial	Particulars of Trial and CTRI Registration Number	Trial Status	Publication	Link(s)
1.	RESILIENT	Encyclopedic Tumor Analysis for Treatment of Refractory / Relapsed Solid Organ Cancers. CTRI/2018/02/011808	Closed	Yes	CTRI/2018/02/011808 Oncotarget Link
2.	RESOLUTE	Detection of Circulating Clusters of Tumor Associated Cells as a Hallmark of Cancer. CTRI/2019/01/017219	Ongoing	Intermediate Data published.	CTRI/2019/01/017219 IJC Link
3.	TRUBLOOD	Use of Circulating Tumor Associated Cells for Non-invasive Diagnosis, Prognosis and Theranostics for Solid Organ Cancers. CTRI/2019/01/017219 CTRI/2019/03/017918	Ongoing	Intermediate Data published.	CTRI/2019/01/017219 CTRI/2019/03/017918 Trublood : Publications
4.	LIQUID-IMPACT	Non-invasive Tumor Analysis using Circulating Tumor Associated Cells for Refractory/ Relapsed Solid Organ Cancers. CTRI/2019/02/017548	Ongoing Recruitment Ended	Not yet.	CTRI/2019/02/017548
5.	GLIOMA	Liquid Biopsy for Differential Diagnosis of Suspected Cases of Brain Malignancies. CTRI/2019/02/017663	Ongoing	Interim Data Published.	CTRI/2019/02/017663 Oxford Neuro-Oncology links 1. Pages vi59–vi60 2. Page vi135 3. Page vi153 4. Pages vi157–vi158
6.	PROSTATE	Non-invasive Biopsy for Differential Diagnosis for Patients with Suspected Prostate Cancer. CTRI/2019/02/017863	Ongoing	Interim Data Published.	CTRI/2019/02/017863 PDF Link

✓All Trials are privately funded.
✓Trials at Sr. No. 1 to 5 are the largest of their kind worldwide till date.

We are open to receive proposals for collaborative research in any of the above areas of cancer science from qualified researchers.

Please contact us for more details.